{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:38:52Z","timestamp":1782232732782,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.ijrobp.2010.09.006","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T22:58:59Z","timestamp":1304981939000},"page":"1889-1896","source":"Crossref","is-referenced-by-count":104,"title":["High-Dose-Rate Brachytherapy as a Monotherapy for Favorable-Risk Prostate Cancer: A Phase II Trial"],"prefix":"10.1016","volume":"82","author":[{"given":"Maroie","family":"Barkati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott G.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Foroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keen Hun","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarat","family":"Chander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"van Dyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"See","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian M.","family":"Duchesne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.09.006_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clon.2004.12.005","article-title":"The emerging role of high-dose-rate brachytherapy for prostate cancer","volume":"17","author":"Morton","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijrobp.2007.12.026","article-title":"A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer","volume":"72","author":"Corner","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brachy.2008.09.004","article-title":"Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy","volume":"8","author":"Ghadjar","year":"2009","journal-title":"Brachytherapy"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00066-004-1215-4","article-title":"3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study","volume":"180","author":"Martin","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0360-3016(00)01463-2","article-title":"Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report","volume":"49","author":"Martinez","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2006.06.011","article-title":"High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer","volume":"80","author":"Yoshioka","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib7","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0360-3016(00)00687-8","article-title":"High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I\/II clinical trial","volume":"48","author":"Yoshioka","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib8","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/01.ju.0000113299.34404.22","article-title":"High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds","volume":"171","author":"Grills","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/COC.0b013e3181b9cd2f","article-title":"High-dose-rate prostate brachytherapy: An excellent accelerated-hypofractionated treatment for favorable prostate cancer","volume":"33","author":"Martinez","year":"2010","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0360-3016(01)02664-5","article-title":"Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha\/beta ratio), similar to late-responding normal tissue","volume":"52","author":"Brenner","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib11","first-page":"747","article-title":"What is the alpha\/beta ratio for prostate cancer? Rationale for hypofractionated high-dose-rate brachytherapy","volume":"44","author":"Duchesne","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(01)01651-0","article-title":"A simple analytic derivation suggests that prostate cancer alpha\/beta ratio is low","volume":"51","author":"King","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2006.12.036","article-title":"Use of individual fraction size data from 3756 patients to directly determine the alpha\/beta ratio of prostate cancer","volume":"68","author":"Williams","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0360-3016(94)90011-6","article-title":"Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer","volume":"30","author":"Diaz","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.urology.2010.04.033","article-title":"Comparison of validated instruments measuring sexual function in men","volume":"76","author":"Levinson","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib16","first-page":"1035","article-title":"American Society for Therapeutic Radiology and Oncology Consensus Panel","volume":"37","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib18","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijrobp.2008.12.051","article-title":"Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer","volume":"75","author":"Konishi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(03)00081-6","article-title":"High-dose-rate brachytherapy as monotherapy for localized prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity","volume":"56","author":"Yoshioka","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.juro.2007.08.136","article-title":"Long-term urinary sequelae following 125iodine prostate brachytherapy","volume":"179","author":"Crook","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib21","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.radonc.2008.11.013","article-title":"Urethral stricture following high dose rate brachytherapy for prostate cancer","volume":"91","author":"Sullivan","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib22","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0090-4295(00)00858-X","article-title":"Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer","volume":"56","author":"Wei","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib23","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1097\/01.ju.0000091426.55735.f0","article-title":"Health related quality of life patterns in patients treated with interstitial prostate brachytherapy for localized prostate cancer: Data from CaPSURE","volume":"170","author":"Downs","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib24","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1200\/JCO.2001.19.6.1619","article-title":"Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer","volume":"19","author":"Madalinska","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/jnci\/djh259","article-title":"Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The prostate cancer outcomes study","volume":"96","author":"Potosky","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib26","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2003.01.199","article-title":"Time course and predictors of symptoms after primary prostate cancer therapy","volume":"21","author":"Talcott","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.09.006_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semradonc.2007.10.001","article-title":"Measuring health-related quality of life consequences from primary treatment for early-stage prostate cancer","volume":"18","author":"Dandapani","year":"2008","journal-title":"Semin Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161003244X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161003244X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T17:30:46Z","timestamp":1543771846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161003244X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S036030161003244X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.006","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}